| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value |
The fair values of the Company’s derivative instruments are disclosed in Note 7—Fair Value Measurements and summarized in the table below: | | | | | | | | | | | | | | | | | Value as of | Balance Sheet Line Item | | August 31, 2026 | | November 30, 2025 | Derivative instruments designated as fair value hedges: | | | | | Cross-currency interest rate swaps (notional value) | | $ | 1,096,679 | | | $ | 1,112,706 | | Other assets | | 2,139 | | | 5,343 | | Other current liabilities and other long-term liabilities | | 50,469 | | | 49,319 | | Derivative instruments designated as cash flow hedges: | | | | | Interest rate swaps (notional value) | | $ | 731,250 | | | $ | 750,000 | | Other long-term assets | | 15,980 | | | — | | Other long-term liabilities | | — | | | 3,357 | | Foreign exchange forward contracts (notional value) | | $ | 1,039,379 | | | $ | 1,049,896 | | Other current assets and other assets | | 961 | | | 914 | | Other accrued liabilities and other long-term liabilities | | 46,534 | | | 21,424 | |
|
| Derivative Instruments, Gain (Loss) |
The following table shows the location of the gains and losses, before taxes, of the Company’s derivative instruments designated as cash flow hedges, fair value hedges, and not designated as hedging instruments in other comprehensive income (loss) (“OCI”), and the consolidated statements of operations for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | Locations of gain (loss) in statement of operations | | August 31, 2026 | | August 31, 2025 | | August 31, 2026 | | August 31, 2025 | Derivative instruments designated as cash flow and fair value hedges: | | | | | | | | | | Gains (losses) recognized in OCI: | | | | | | | | | | Foreign exchange forward contracts | | | $ | (4,900) | | | $ | (22,989) | | | $ | (54,868) | | | $ | 12,892 | | Cross-currency interest rate swaps | | | 3,416 | | | 4,076 | | | (2,230) | | | 4,758 | | Interest rate swaps | | | 6,520 | | | — | | | 19,337 | | | — | | Total | | | $ | 5,036 | | | $ | (18,913) | | | $ | (37,761) | | | $ | 17,650 | | | | | | | | | | | | Gains (losses) reclassified from AOCL into income: | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | Gain (loss) reclassified from AOCL into income | Cost of revenue | | $ | (9,395) | | | $ | 564 | | | $ | (21,249) | | | $ | (3,576) | | Gain (loss) reclassified from AOCL into income | Selling, general and administrative expenses | | (3,502) | | | 167 | | | (8,557) | | | (1,286) | | Total | | | $ | (12,897) | | | $ | 731 | | | $ | (29,806) | | | $ | (4,862) | | | | | | | | | | | | Derivative instruments not designated as hedging instruments: | | | | | | | | | | Gain (loss) recognized from foreign exchange forward contracts, net (1) | Other expense (income), net | | $ | — | | | $ | 5,118 | | | $ | — | | | $ | 5,858 | |
|